Dehydrophenylalanine derivatives as VLA-4 integrin antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 5, 2003, Pages 805-808

  Porter, John R ^a   Archibald, Sarah C ^a   Brown, Julien A ^a   Childs, Kirstie ^a   Critchley, David ^a   Head, John C ^a   Parton, Ted A H ^a   Robinson, Martyn K ^a   Shock, Anthony ^a   Taylor, Richard J ^a   Warrellow, Graham J ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BLOCKING AGENT; CD29 ANTIGEN ANTAGONIST; INTEGRIN; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG CLEARANCE; DRUG DESIGN; DRUG POTENCY; HEPATOBILIARY SYSTEM; ISOMER;

ANIMALS; BENZODIAZEPINES; BILIARY TRACT; DRUG DESIGN; INHIBITORY CONCENTRATION 50; INTEGRIN ALPHA4BETA1; ISOMERISM; PHENYLALANINE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037430541     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00019-2     Document Type: Article

References (19)

1. Hynes R. Cell. 48:1987;554.
2. Plow E., Haas T., Zhang L., Loftus J., Smith J. J. Biol. Chem. 275:2000;21785.
3. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. Cell. 60:1990;577.
4. Yusuf-Makagiansar H., Anderson M.E., Yakovleva T.Y., Murray J.S., Siahaan T.J. Med. Res. Rev. 22:2002;146.
5. Elices M.J. Cell Adhesion Molecules and Matrix Proteins: Role in Health and Diseases. Mousa S.A. 1998;133-147 Springer-Verlag and R. G. Landes Co, Berlin.
6. Sorbera L.A., Martin L., Rabasseda X. Drugs Future. 25:2000;917. Elices M. Curr. Opin. Anti-Inflamm. Immunomod. Invest. Drugs. 2:2000;228.
7. Sorbera L.A., Martin L., Rabasseda X. Drugs Future. 25:2000;917. Elices M. Curr. Opin. Anti-Inflamm. Immunomod. Invest. Drugs. 2:2000;228.
8. (a) Porter J.R. IDrugs. 3:2000;788.
9. (b) Tilley J.W., Sidduri A. Drugs of the Future. 26:2001;985.
10. (c) Jackson D.Y. Curr. Pharm. Des. 8:2002;1229.
11. Archibald S.C., Head J.C., Gozzard N., Howat D.W., Parton A.H., Porter J.R., Robinson M.K., Shock A., Warrellow G.J., Abraham W.M. Bioorg. Med. Chem. Lett. 10:2000;997.
12. See for example (a) Hagmann W.K., Durette P.L., Lanza T., Kevin N.J., de Laszlo S.E., Kopka I.E., Young D., Magriotis P.A., Li B., Lin L.S., Yang G., Kamenecka T., Chang L.L., Wilson J., MacCoss M., Mills S.G., Van Riper G., McCauley E., Egger L.A., Kidambi U., Lyons K., Vincent S., Stearns R., Colletti A., Teffera J., Tong S., Fenyk-Melody J., Owens K., Levorse D., Kim P., Schmidt J.A., Mumford R.A. Bioorg. Med. Chem. Lett. 11:2001;2709. (b) Chen L., Trilles R., Miklowski D., Huang T.-L., Fry D., Campbell R., Rowan K., Schwinge V., Tilley J.W. Bioorg. Med. Chem. Lett. 12:2002;1679.
13. See for example (a) Hagmann W.K., Durette P.L., Lanza T., Kevin N.J., de Laszlo S.E., Kopka I.E., Young D., Magriotis P.A., Li B., Lin L.S., Yang G., Kamenecka T., Chang L.L., Wilson J., MacCoss M., Mills S.G., Van Riper G., McCauley E., Egger L.A., Kidambi U., Lyons K., Vincent S., Stearns R., Colletti A., Teffera J., Tong S., Fenyk-Melody J., Owens K., Levorse D., Kim P., Schmidt J.A., Mumford R.A. Bioorg. Med. Chem. Lett. 11:2001;2709. (b) Chen L., Trilles R., Miklowski D., Huang T.-L., Fry D., Campbell R., Rowan K., Schwinge V., Tilley J.W. Bioorg. Med. Chem. Lett. 12:2002;1679.
14. Frink E., Kramer T., Banchy S., Brown B. Anesth. Analg. 71:1990;484.
15. 2, 0.1% Tween. After incubation for 2 h at room temperature the plates were washed and residual VCAM visualised with peroxidase coupled anti-human Fc.
16. A Jurkat cell line expressing VLA4 was incubated at 37°C for 30 min with human 2-domain VCAM-1-FC immobilised on a plate with anti-human FC in the presence of the test compounds. The plates were washed and residual cells were stained with Rose Bengal.
17. 1H resonances are resolved at 7.31 ppm (major) and 7.40 ppm (minor). In the NOESY data no crosspeaks are observed corresponding to these resonances. Weak, positively phased nOe crosspeaks are observed between the two NH resonances in each conformer at 9.39 ppm (major) and 9.66 ppm (minor) and the higher frequency phenylalanine AA′BB′ multiplet resonance centred at 7.67 ppm. This identifies 5 as the Z isomer. Parallel data was recorded for the other isomeric pairs of molecules.
18. Porter J.R., Archibald S.C., Childs K., Critchley D., Head J.C., Linsley J., Parton T.A.H., Robinson M.K., Shock A., Taylor R.J., Warrellow G.J., Alexander R., Langham B. Bioorg. Med. Chem. Lett. 12:2002;1051.
19. Wamhoff H., Rechardt G., Stölben S. Advances in Hetreocyclic Chemistry. 64:1996;159.